EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial

Divaka Perera iD, Holly P Morgan iD, Matthew Ryan, Matthew Dodd iD, Tim Clayton iD, Peter D O'Kane iD, John P Greenwood iD, Simon J Walsh, Roshan Weerackody, Adam McDiarmid, George Amin-Youssef, Julian Strange iD und 13 weitere

Circulation · 12.09.2023 · 148 (11) · 862-871

DOI: 10.1161/circulationaha.123.065300 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 12.09.2023. Verfasst von Divaka Perera und 24 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Health Research Biomedical Research Center and British Heart Foundation Center of Research Excellence at the School of Cardiov…. Hauptthemen laut MEDLINE: Ventricular Dysfunction, Left, Defibrillators, Implantable. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ventricular arrhythmia is an important cause of mortality in patients with ischemic left ventricular dysfunction. Revascularization with coronary artery bypass graft or percutaneous coronary intervention is often recommended for these patients before implantation of a cardiac defibrillator because it is assumed that this may reduce the incidence of fatal and potentially fatal ventricular arrhythmias, although this premise has not been evaluated in a randomized trial to date. METHODS: Patients with severe left ventricular dysfunction, extensive coronary disease, and viable myocardium were randomly assigned to receive either percutaneous coronary intervention (PCI) plus optimal medical and device therapy (OMT) or OMT alone. The composite primary outcome was all-cause death or aborted sudden death (defined as an appropriate implantable cardioverter defibrillator therapy or a resuscitated cardiac arrest) at a minimum of 24 months, analyzed as time to first event on an intention-to-treat basis. Secondary outcomes included cardiovascular death or aborted sudden death, appropriate implantable cardioverter defibrillator (ICD) therapy or sustained ventricular arrhythmia, and number of appropriate ICD therapies. RESULTS: Between August 28, 2013, and March 19, 2020, 700 patients were enrolled across 40 centers in the United Kingdom. A total of 347 patients were assigned to the PCI+OMT group and 353 to the OMT alone group. The mean age of participants was 69 years; 88% were male; 56% had hypertension; 41% had diabetes; and 53% had a clinical history of myocardial infarction. The median left ventricular ejection fraction was 28%; 53.1% had an implantable defibrillator inserted before randomization or during follow-up. All-cause death or aborted sudden death occurred in 144 patients (41.6%) in the PCI group and 142 patients (40.2%) in the OMT group (hazard ratio, 1.03 [95% CI, 0.82–1.30]; P =0.80). There was no between-group difference in the occurrence of any of the secondary outcomes. CONCLUSIONS: PCI was not associated with a reduction in all-cause mortality or aborted sudden death. In patients with ischemic cardiomyopathy, PCI is not beneficial solely for the purpose of reducing potentially fatal ventricular arrhythmias. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01920048.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular Dysfunction, LeftDefibrillators, ImplantableHumansMaleAgedFemaleStroke VolumeDeath, Sudden, CardiacVentricular Function, LeftArrhythmias, CardiacTreatment Outcome

Stichwörter der Autor:innen

arrhythmias, cardiaccardiomyopathiesdeath, sudden, cardiacdefibrillators, implantableheart failuremyocardial revascularizationpercutaneous coronary intervention

Autor:innen und Institutionen

  • National Institute for Health Research Biomedical Research Center and British Heart Foundation Center of Research Excellence at the School of Cardiovascular Medicine and Sciences, King's College London, United Kingdom (…
  • Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom (D.P., C.A.R.).
  • London School of Hygiene & Tropical Medicine, United Kingdom (M.D., T.C., R.E.).
  • Royal Bournemouth and Christchurch Hospital, Bournemouth, United Kingdom (P.D.O.).
  • Leeds Teaching Hospitals NHS Trust and University of Leeds, United Kingdom (J.P.G., M.A.).
  • Belfast Health and Social Care NHS Trust, United Kingdom (S.J.W.).

ORCID-Profile: Divaka Perera, Holly P Morgan, Matthew Dodd, Tim Clayton, Peter D O'Kane, John P Greenwood, Julian Strange, Fozia Z Ahmed, Michelle Anderson, Stuart Watkins, Mark C Petrie

Förderung

  • Department of Health
  • British Heart Foundation

Zitieren

APA

Perera, D., Morgan, H. P., Ryan, M., Dodd, M., Clayton, T., O'Kane, P. D., Greenwood, J. P., Walsh, S. J., Weerackody, R., McDiarmid, A., Amin-Youssef, G., Strange, J., Modi, B., Lockie, T., Hogrefe, K., Ahmed, F. Z., Behan, M., Jenkins, N., Abdelaal, E., …, & REVIVED-BCIS2 Investigators (2023). Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial. Circulation, 148(11), 862-871. https://doi.org/10.1161/circulationaha.123.065300

Vancouver

Perera D, Morgan HP, Ryan M, Dodd M, Clayton T, O'Kane PD, et al. Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial. Circulation. 2023;148(11):862-871. doi:10.1161/circulationaha.123.065300

BibTeX
@article{Perera2023,
  author = {Perera, Divaka and Morgan, Holly P and Ryan, Matthew and Dodd, Matthew and Clayton, Tim and O'Kane, Peter D and Greenwood, John P and Walsh, Simon J and Weerackody, Roshan and McDiarmid, Adam and Amin-Youssef, George and Strange, Julian and Modi, Bhavik and Lockie, Timothy and Hogrefe, Kai and Ahmed, Fozia Z and Behan, Miles and Jenkins, Nicholas and Abdelaal, Eltigani and Anderson, Michelle and Watkins, Stuart and Evans, Richard and Rinaldi, Christopher A and Petrie, Mark C and REVIVED-BCIS2 Investigators, REVIVED-BCIS2 Investigators},
  title = {Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial},
  journal = {Circulation},
  year = {2023},
  volume = {148},
  number = {11},
  pages = {862--871},
  doi = {10.1161/circulationaha.123.065300}
}
Kostenlos starten →